These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 23192155
1. Increased urinary CCL2: Cr ratio at 6 months is associated with late renal allograft loss. Ho J, Wiebe C, Rush DN, Rigatto C, Storsley L, Karpinski M, Gao A, Gibson IW, Nickerson PW. Transplantation; 2013 Feb 27; 95(4):595-602. PubMed ID: 23192155 [Abstract] [Full Text] [Related]
2. Elevated urinary CCL2: Cr at 6 months is associated with renal allograft interstitial fibrosis and inflammation at 24 months. Ho J, Wiebe C, Gibson IW, Hombach-Klonisch S, Gao A, Rigatto C, Karpinski M, Storsley L, Nickerson PW, Rush DN. Transplantation; 2014 Jul 15; 98(1):39-46. PubMed ID: 24646773 [Abstract] [Full Text] [Related]
3. Six-Month Urinary CCL2 and CXCL10 Levels Predict Long-term Renal Allograft Outcome. Hirt-Minkowski P, Rush DN, Gao A, Hopfer H, Wiebe C, Nickerson PW, Schaub S, Ho J. Transplantation; 2016 Sep 15; 100(9):1988-96. PubMed ID: 27548845 [Abstract] [Full Text] [Related]
4. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts. Ho J, Rush DN, Gibson IW, Karpinski M, Storsley L, Bestland J, Stefura W, HayGlass KT, Nickerson PW. Transplantation; 2010 Aug 27; 90(4):394-400. PubMed ID: 20625355 [Abstract] [Full Text] [Related]
5. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction. Khalkhali HR, Ghafari A, Hajizadeh E, Kazemnejad A. Exp Clin Transplant; 2010 Dec 27; 8(4):277-82. PubMed ID: 21143092 [Abstract] [Full Text] [Related]
6. Advantages of kidney transplant precocity in graft long-term survival. Malho A, Malheiro J, Fonseca I, Martins LS, Pedroso S, Almeida M, Dias L, Castro Henriques A, Cabrita A. Transplant Proc; 2012 Oct 27; 44(8):2344-7. PubMed ID: 23026589 [Abstract] [Full Text] [Related]
7. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. Kamali K, Abbasi MA, Farokhi B, Abbasi A, Fallah P, Seifee MH, Ghadimi N, Rezaie AR. Exp Clin Transplant; 2009 Dec 27; 7(4):237-40. PubMed ID: 20353374 [Abstract] [Full Text] [Related]
8. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients. Oterdoom LH, van Ree RM, de Vries AP, Gansevoort RT, Schouten JP, van Son WJ, Homan van der Heide JJ, Navis G, de Jong PE, Gans RO, Bakker SJ. Transplantation; 2008 Aug 15; 86(3):391-8. PubMed ID: 18698241 [Abstract] [Full Text] [Related]
9. Early posttransplantation hyperglycemia in kidney transplant recipients is associated with overall long-term graft losses. Valderhaug TG, Hjelmesæth J, Jenssen T, Røislien J, Leivestad T, Hartmann A. Transplantation; 2012 Oct 15; 94(7):714-20. PubMed ID: 22965263 [Abstract] [Full Text] [Related]
10. Pretransplant serum phosphate levels and outcomes after kidney transplantation. Sapir-Pichhadze R, Parmar K, Kim SJ. J Nephrol; 2012 Oct 15; 25(6):1091-7. PubMed ID: 22383343 [Abstract] [Full Text] [Related]
11. Donor-recipient age difference and graft survival in living donor kidney transplantation. Lee YJ, Chang JH, Choi HN, Jung JY, Kim YS, Chung WK, Park YH, Lee HH. Transplant Proc; 2012 Jan 15; 44(1):270-2. PubMed ID: 22310630 [Abstract] [Full Text] [Related]
12. Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and clinical rejection in pediatric renal transplantation. Blydt-Hansen TD, Gibson IW, Gao A, Dufault B, Ho J. Transplantation; 2015 Apr 15; 99(4):797-804. PubMed ID: 25222013 [Abstract] [Full Text] [Related]
13. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA. Nephrol Dial Transplant; 1996 Jun 15; 11(6):1096-103. PubMed ID: 8671975 [Abstract] [Full Text] [Related]
14. Increased recipient body mass index is associated with acute rejection and other adverse outcomes after kidney transplantation. Curran SP, Famure O, Li Y, Kim SJ. Transplantation; 2014 Jan 15; 97(1):64-70. PubMed ID: 24056619 [Abstract] [Full Text] [Related]
15. Very early serum creatinine as a surrogate marker for graft survival beyond 10 years. Pascual J, Marcén R, Zamora J, Fernández AM, Burgos FJ, Villafruela JJ, Ortuño J. J Nephrol; 2009 Jan 15; 22(1):90-8. PubMed ID: 19229823 [Abstract] [Full Text] [Related]
16. Urinary biomarkers of renal transplant outcome. Ho J, Rush DN, Nickerson PW. Curr Opin Organ Transplant; 2015 Aug 15; 20(4):476-81. PubMed ID: 26107968 [Abstract] [Full Text] [Related]
17. The independent association between serum uric acid and graft outcomes after kidney transplantation. Haririan A, Nogueira JM, Zandi-Nejad K, Aiyer R, Hurley H, Cooper M, Klassen DK, Weir MR. Transplantation; 2010 Mar 15; 89(5):573-9. PubMed ID: 19997058 [Abstract] [Full Text] [Related]
18. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients. Gentil Govantes MA, Esforzado N, Cruzado JM, González-Roncero FM, Balaña M, Saval N, Morales JM. Transplantation; 2012 Dec 15; 94(11):1131-7. PubMed ID: 23104249 [Abstract] [Full Text] [Related]
19. Delayed graft function after renal transplantation: an unresolved problem. Gavela Martínez E, Pallardó Mateu LM, Sancho Calabuig A, Beltrán Catalán S, Kanter Berga J, Ávila Bernabeu AI, Crespo Albiach J. Transplant Proc; 2011 Dec 15; 43(6):2171-3. PubMed ID: 21839224 [Abstract] [Full Text] [Related]
20. Transplantation with kidneys retrieved from deceased donors with acute renal failure. Klein R, Galante NZ, de Sandes-Freitas TV, de Franco MF, Tedesco-Silva H, Medina-Pestana JO. Transplantation; 2013 Feb 27; 95(4):611-6. PubMed ID: 23274968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]